Skip to content

Inspiratory muscle training in patients with asthma

Effects of a high intensity inspiratory muscle training program versus an education program on inspiratory muscle strengh and endurance, functional capacity and quality of life in patients with asthma: a randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33794377
Enrollment
40
Registered
2016-04-15
Start date
2016-05-20
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Respiratory Asthma

Interventions

Description of intervention: 1. IMT Group (IMT plus educational program) 2. Control Group (educational program) Inspiratory muscle training (IMT): six

Sponsors

Federal University of Minas Gerais
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with asthma according to GINA - an increase in FEV1 of > 12% and 200mL after administration of a bronchodilator indicates reversible airflow limitation consistent with asthma 2. Age between 20 and 70 years old 3. No smokers 4. Asthma control test above 18 points; 5.- Auto report of absence of cardiac and neurological diseases

Exclusion criteria

Exclusion criteria: 1. Fever 2. Flu symptoms or respiratory infection in the seven days prior to evaluation 3. Orthopedic and neurological problems 4. Inability to understand or carry out any study procedures

Design outcomes

Primary

MeasureTime frame
1. Inspiratory muscle strength - maximal inspiratory pressure assessed by a digital manovacuometer 2. Inspiratory muscle endurance – time, volume, flow, work and power assessed by an electronic tapered flow resistive loading device 3. Functional capacity – maximal distance covered during shuttle walking test 4. Quality of life - Brazilian version of the Asthma Quality of Life Questionnaire Assessed at baseline, 8 weeks and 3 months.

Secondary

MeasureTime frame
1. Lung function: Forced expiratory volume in the first second-FEV1, forced vital capacity-FVC and peak expiratory flow-PEF 2. Hospital admissions 3. Number of exacerbations Assessed at baseline, 8 weeks and 3 months.

Countries

Brazil

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026